Veterinary Medicines

L-SPEC, süstelahus

Authorised
  • Lincomycin hydrochloride
  • Spectinomycin dihydrochloride pentahydrate
Download as PDF

Product identification

Medicine name:
L-SPEC, süstelahus
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin dihydrochloride pentahydrate
Target species:
  • Cattle (pre-ruminant)
  • Pig
  • Sheep
  • Goat
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    54.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin dihydrochloride pentahydrate
    149.10
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (pre-ruminant)
      • Meat and offal
        21
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        15
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        15
        day
      • Milk
        no withdrawal period
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2050
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 14/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."